Loading...
Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
BACKGROUND & AIMS: We determined the optimal HCV treatment prioritization strategy for interferon-free (IFN-free) HCV direct-acting antivirals (DAAs) by disease stage and risk status incorporating treatment of people who inject drugs (PWID). METHODS: A dynamic HCV transmission and progression mo...
Na minha lista:
| Udgivet i: | J Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4914770/ https://ncbi.nlm.nih.gov/pubmed/26867489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2016.02.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|